AR004158A1 - Compuesto de ftalizin-pirido dionas; composición farmacéutica que lo contiene; y proceso para la preparación de dicho compuesto. - Google Patents
Compuesto de ftalizin-pirido dionas; composición farmacéutica que lo contiene; y proceso para la preparación de dicho compuesto.Info
- Publication number
- AR004158A1 AR004158A1 ARP970103380A ARP970103380A AR004158A1 AR 004158 A1 AR004158 A1 AR 004158A1 AR P970103380 A ARP970103380 A AR P970103380A AR P970103380 A ARP970103380 A AR P970103380A AR 004158 A1 AR004158 A1 AR 004158A1
- Authority
- AR
- Argentina
- Prior art keywords
- compound
- ftalizin
- dionas
- pirido
- preparation
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
- C07D237/26—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings condensed with carbocyclic rings or ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4166—1,3-Diazoles having oxo groups directly attached to the heterocyclic ring, e.g. phenytoin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/38—Cellulose; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, ***e
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Neurology (AREA)
- Epidemiology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Inorganic Chemistry (AREA)
- Pain & Pain Management (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Psychiatry (AREA)
- Gastroenterology & Hepatology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Abstract
Ftalazin-pirido-dionas que tienen la fórmula (I), donde R1 y R2 se seleccionan entre el grupo integrado por hidrógeno, halógeno, y metoxi ó dondeR1 y R2 juntos forman metilendioxi y sales farmacéuticamente aceptables de las mismas, y compos icionesfarmacéuticas que contienen una cantidad del mismosefectiva como antagonista de glicinaB, son útiles para combatir los trastornos neurológicos asociados con la excitotoxicidad y el mal funcionamiento de laneurotransmisión glutamatérgica en u nanimal vivo, incluido el ser humano, que tenga necesidad de ello. La invención también se refiee a un proceso parapreparar dichos compuestos que comprende convertir el derivado de quinolina correspondiente en la sal de hidrazina e hidrolizar l asal resultante paraproducir el compuesto deseado.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/686,346 US5776935A (en) | 1996-07-25 | 1996-07-25 | Pyrido-phtalazin diones and their use against neurological disorders associated with excitotoxicity and malfunctioning of glutamatergic neurotransmission |
Publications (1)
Publication Number | Publication Date |
---|---|
AR004158A1 true AR004158A1 (es) | 1998-11-04 |
Family
ID=24755940
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP970103380A AR004158A1 (es) | 1996-07-25 | 1997-07-25 | Compuesto de ftalizin-pirido dionas; composición farmacéutica que lo contiene; y proceso para la preparación de dicho compuesto. |
Country Status (31)
Country | Link |
---|---|
US (1) | US5776935A (es) |
EP (1) | EP0931081B1 (es) |
JP (1) | JP3595342B2 (es) |
KR (1) | KR100598206B1 (es) |
CN (1) | CN1093860C (es) |
AR (1) | AR004158A1 (es) |
AT (1) | ATE224894T1 (es) |
AU (1) | AU719993B2 (es) |
BR (1) | BR9710569A (es) |
CA (1) | CA2261923C (es) |
CZ (1) | CZ289293B6 (es) |
DE (1) | DE69715893T2 (es) |
DK (1) | DK0931081T3 (es) |
EA (1) | EA001711B1 (es) |
ES (1) | ES2180041T3 (es) |
FI (1) | FI112946B (es) |
GE (1) | GEP20022801B (es) |
HK (1) | HK1020193A1 (es) |
HU (1) | HU223780B1 (es) |
IL (1) | IL128225A (es) |
LT (1) | LT4591B (es) |
LV (1) | LV12260B (es) |
NO (1) | NO310820B1 (es) |
PL (1) | PL189572B1 (es) |
PT (1) | PT931081E (es) |
SI (1) | SI9720048B (es) |
SK (1) | SK283536B6 (es) |
TW (1) | TW402605B (es) |
UA (1) | UA63911C2 (es) |
WO (1) | WO1998004556A1 (es) |
ZA (1) | ZA976612B (es) |
Families Citing this family (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20030176435A1 (en) * | 2002-12-17 | 2003-09-18 | Brown Dean Gordon | Compounds and methods for the treatment of pain |
US6444702B1 (en) | 2000-02-22 | 2002-09-03 | Neuromolecular, Inc. | Aminoadamantane derivatives as therapeutic agents |
WO2003015713A2 (en) * | 2001-08-20 | 2003-02-27 | Maiken Nedergaard | Treatment of glial tumors with glutamate antagonists |
EP1298581A1 (fr) * | 2001-09-27 | 2003-04-02 | C.S.E.M. Centre Suisse D'electronique Et De Microtechnique Sa | Procédé et dispositif pour calculer les valeurs des neurones d'un réseau neuronal |
US20050069596A1 (en) * | 2001-10-03 | 2005-03-31 | Gow Robert T. | Compositions and methods comprising kava and anti-anxiety compounds |
US7001620B2 (en) | 2001-10-03 | 2006-02-21 | Herbal Science, Llc | Kavalactone product |
US7029707B2 (en) * | 2001-10-03 | 2006-04-18 | Herbalscience, Llc | Method of producing a processed kava product having an altered kavalactone distribution and processed kava products produced using the same |
US7291352B2 (en) | 2001-10-03 | 2007-11-06 | Herbalscience Llc | Methods and compositions for oral delivery of Areca and mate' or theobromine |
US7105185B2 (en) | 2001-10-03 | 2006-09-12 | Herbalscience, Llc | Kavalactone profile |
US7037524B2 (en) * | 2001-10-03 | 2006-05-02 | Herbalscience, Llc | Oral delivery of a botanical |
US20050037025A1 (en) * | 2002-10-03 | 2005-02-17 | Gow Robert T. | Methods and compositions comprising kava and mate' or theobromine |
US20040082543A1 (en) * | 2002-10-29 | 2004-04-29 | Pharmacia Corporation | Compositions of cyclooxygenase-2 selective inhibitors and NMDA receptor antagonists for the treatment or prevention of neuropathic pain |
CN1917892A (zh) * | 2003-10-24 | 2007-02-21 | 草本制药科学有限责任公司 | 包含冬青的方法和组合物 |
US7294353B2 (en) * | 2003-10-24 | 2007-11-13 | Herbalscience, Llc | Methods and compositions comprising ilex |
EP1868587A2 (en) * | 2005-04-08 | 2007-12-26 | Abbott Laboratories | Pharmaceutical formulations comprising fenofibric acid and/or its salts |
NZ584098A (en) * | 2007-09-20 | 2012-05-25 | Cortex Pharma Inc | 3-substituted 1,2,3-triazin-4-one's and 3-substituted 1,3-pyrimidinone's for enhancing glutamatergic synaptic responses |
EP2264035A1 (en) * | 2009-06-04 | 2010-12-22 | Merz Pharma GmbH & Co. KGaA | Glycine B antagonists |
US9737531B2 (en) | 2012-07-12 | 2017-08-22 | Glytech, Llc | Composition and method for treatment of depression and psychosis in humans |
KR102609676B1 (ko) | 2017-06-12 | 2023-12-05 | 글리테크 엘엘씨. | Nmda 길항제 및 d2/5ht2a 또는 선택적 5ht2a 길항제를 이용한 우울증의 치료 |
USD895157S1 (en) | 2018-03-06 | 2020-09-01 | IsoTruss Indsutries LLC | Longitudinal beam |
CN109912503B (zh) * | 2019-04-01 | 2022-04-08 | 江南大学 | 一种2,3-二酰基喹啉类化合物的合成方法 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9208511D0 (en) * | 1991-05-09 | 1992-06-03 | Ici Plc | Compounds |
US5597922A (en) * | 1994-07-29 | 1997-01-28 | State Of Oregon, Acting By And Through The Oregon State Board Of Higher Education, Acting For And On Behalf Of The Oregon Health Sciences University And The University Of Oregon | Glycine receptor antagonist pharmacophore |
-
1996
- 1996-07-25 US US08/686,346 patent/US5776935A/en not_active Expired - Fee Related
-
1997
- 1997-07-23 TW TW086110479A patent/TW402605B/zh not_active IP Right Cessation
- 1997-07-24 ZA ZA9706612A patent/ZA976612B/xx unknown
- 1997-07-25 IL IL12822597A patent/IL128225A/xx not_active IP Right Cessation
- 1997-07-25 GE GEAP19974684A patent/GEP20022801B/en unknown
- 1997-07-25 SK SK103-99A patent/SK283536B6/sk unknown
- 1997-07-25 EP EP97918944A patent/EP0931081B1/en not_active Expired - Lifetime
- 1997-07-25 CA CA002261923A patent/CA2261923C/en not_active Expired - Fee Related
- 1997-07-25 PT PT97918944T patent/PT931081E/pt unknown
- 1997-07-25 DE DE69715893T patent/DE69715893T2/de not_active Expired - Fee Related
- 1997-07-25 AR ARP970103380A patent/AR004158A1/es active IP Right Grant
- 1997-07-25 UA UA99021084A patent/UA63911C2/uk unknown
- 1997-07-25 EA EA199900161A patent/EA001711B1/ru not_active IP Right Cessation
- 1997-07-25 JP JP50849998A patent/JP3595342B2/ja not_active Expired - Fee Related
- 1997-07-25 WO PCT/EP1997/004057 patent/WO1998004556A1/en active IP Right Grant
- 1997-07-25 CN CN97197534A patent/CN1093860C/zh not_active Expired - Fee Related
- 1997-07-25 HU HU9903104A patent/HU223780B1/hu active IP Right Grant
- 1997-07-25 AU AU42969/97A patent/AU719993B2/en not_active Ceased
- 1997-07-25 PL PL97331323A patent/PL189572B1/pl not_active IP Right Cessation
- 1997-07-25 SI SI9720048A patent/SI9720048B/sl not_active IP Right Cessation
- 1997-07-25 DK DK97918944T patent/DK0931081T3/da active
- 1997-07-25 KR KR1019997000627A patent/KR100598206B1/ko not_active IP Right Cessation
- 1997-07-25 ES ES97918944T patent/ES2180041T3/es not_active Expired - Lifetime
- 1997-07-25 BR BR9710569A patent/BR9710569A/pt not_active Application Discontinuation
- 1997-07-25 AT AT97918944T patent/ATE224894T1/de not_active IP Right Cessation
- 1997-07-25 CZ CZ1999201A patent/CZ289293B6/cs unknown
-
1999
- 1999-01-22 NO NO19990306A patent/NO310820B1/no unknown
- 1999-01-22 LV LVP-99-14A patent/LV12260B/en unknown
- 1999-01-25 LT LT99-007A patent/LT4591B/lt not_active IP Right Cessation
- 1999-01-25 FI FI990134A patent/FI112946B/fi active
- 1999-11-02 HK HK99104938A patent/HK1020193A1/xx not_active IP Right Cessation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AR004158A1 (es) | Compuesto de ftalizin-pirido dionas; composición farmacéutica que lo contiene; y proceso para la preparación de dicho compuesto. | |
CY1118191T1 (el) | Αναλογα δεοξυνοζιριμυκινης και οι χρησεις τους ως αναστολεις γλυκοζυλοκεραμιδασης | |
ECSP034562A (es) | Agonista del receptor b3-adrenergico y usos de los mismos | |
DOP2006000084A (es) | Compuestos sulfoximino-macrociclicos y sus sales, composiciones farmaceuticas que comprenden dichos compuestos, metodos de preparacion y usos de los mismos | |
ES2158814B1 (es) | Derivados de pirrolidina antagonistas del receptor ccr-3 | |
AR021844A1 (es) | Derivados de propanolamina aril-sustituidos, procedimientos para su preparacion, medicamentos que contienen estos compuestos y su utilizacion | |
AR028810A1 (es) | Derivados de arilpiperazinil-ciclohexil indol, composiciones farmaceuticas que los comprenden y el uso de los mismos para la manufactura de medicamentos para el tratamiento de la depresion | |
ES2064310T3 (es) | Procedimiento para preparar compuestos de imidazopiridina. | |
GT200100137A (es) | Pro-drogas de derivados de 4-fenil-piridina. | |
CY1109457T1 (el) | Παραγωγο aminoαλκοολης ή παραγωγο φωσφονικου οξεος και φαρμακευτικη συνθεση που τα περιεχει | |
ES2112650T3 (es) | Sales de un derivado de indol antimigraña. | |
ES2196377T3 (es) | Derivados de naftiridina. | |
ES2185999T3 (es) | Derivados de quinazolina y composiciones farmaceuticas que los contienen. | |
UY28496A1 (es) | Compuestos de bencimidazolona que tienen actividad agonista del receptor 5-ht4 | |
BRPI0313942C1 (pt) | derivados de benzimidazol úteis como agentes antiproliferativos, seus processos de preparação, composição farmacêutica compreendendo os mesmos e usos dos referidos compostos nas preparações de composições farmacêuticas | |
EA200200716A1 (ru) | Арилконденсированные азаполициклические соединения | |
NO20043367L (no) | Oralt farmasoytisk preparat | |
PA8456901A1 (es) | 2-aminopiridinas que contienen sustituyentes de anillos condensados | |
ES2179353T3 (es) | Antagonistas muscarinicos. | |
AR024060A1 (es) | Nuevos compuestos farmaceuticamente activos | |
PA8556801A1 (es) | Compuestos de imidazopiridin como moduladores de receptor 5-ht 4 | |
ES2158813B1 (es) | Sales cuaternarias de piperidina antagonistas del receptor ccr-3 | |
PA8495101A1 (es) | Derivados de 13-metileritromicina | |
BRPI0411673A (pt) | composto, sal farmaceuticamente aceitável, composição farmacêutica, e, uso de um composto | |
UY27023A1 (es) | Derivados de fenil cetonas sustituidas como antagonistas de ip |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Grant, registration |